Literature DB >> 32843169

Diffusing capacity in normal-for-age spirometry and spirometric impairments, using reference equations from the global lung function initiative.

Carlos A Vaz Fragoso1, Carolyn L Rochester2, Gail J McAvay3, Lynne Iannone2, Linda S Leo-Summers3.   

Abstract

BACKGROUND: Reference equations from the Global Lung Function Initiative (GLI) are now available for both spirometry and diffusion. However, respiratory phenotypes defined by GLI-based measures of diffusion have not yet been evaluated in GLI-based normal-for-age spirometry or spirometric impairments.
METHODS: We evaluated cross-sectional data from 2100 Caucasians, aged 40-85 years. GLI-based spirometric categories included normal-for-age and the impairments of restrictive-pattern and three-level severity of airflow-obstruction (mild, moderate, severe). GLI-based diffusion included diffusing capacity of the lung for carbon monoxide (DLCO) and measured components of alveolar volume (VA) and transfer coefficient (KCO): DLCO = [VA]x[KCO]. Using multivariable regression models, adjusted odds ratios (adjORs) for DLCO, VA, and KCO < lower limit of normal (LLN) were calculated for spirometric impairments, relative to normal-for-age spirometry.
RESULTS: Relative to normal-for-age spirometry, the restrictive-pattern increased the adjORs (95% confidence intervals) for DLCO and VA < LLN-4.61 (3.62, 5.85) and 15.53 (11.8, 20.4), respectively, but not for KCO < LLN-1.02 (0.79, 1.33). Also relative to normal-for-age spirometry, airflow-obstruction from mild to severe increased the adjORs for DLCO < LLN-from 1.22 (0.80, 1.86) to 6.63 (4.91, 8.95), for VA < LLN-from 1.37 (0.85, 2.18) to 7.01 (5.20, 9.43), and for KCO < LLN-from 2.04 (1.33, 3.14) to 3.03 (2.29, 3.99). Notably, in normal-for-age spirometry, 34.5%, 19.7%, and 25.3% of participants had DLCO, VA, or KCO < LLN, respectively.
CONCLUSION: Abnormal diffusion is most prevalent in spirometric impairments but also occurs in normal-for-age spirometry. These results further inform the respiratory phenotypes of GLI-based spirometric categories and, in turn, the spirometric evaluation of respiratory disease.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Diffusion; GLI; Obstruction; Restriction; Spirometry

Mesh:

Year:  2020        PMID: 32843169      PMCID: PMC7453093          DOI: 10.1016/j.rmed.2020.106037

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  41 in total

1.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Reference ranges for spirometry across all ages: a new approach.

Authors:  Sanja Stanojevic; Angie Wade; Janet Stocks; John Hankinson; Allan L Coates; Huiqi Pan; Mark Rosenthal; Mary Corey; Patrick Lebecque; Tim J Cole
Journal:  Am J Respir Crit Care Med       Date:  2007-11-15       Impact factor: 21.405

4.  Spirometry, Static Lung Volumes, and Diffusing Capacity.

Authors:  Carlos A Vaz Fragoso; Hilary C Cain; Richard Casaburi; Patty J Lee; Lynne Iannone; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

Review 5.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

7.  BMI and magnitude of scoliosis at presentation to a specialty clinic.

Authors:  Shawn R Gilbert; Albert J Savage; Rebecca Whitesell; Michael J Conklin; Naomi S Fineberg
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

8.  Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.

Authors:  Andrea Gershon; Ruth Croxford; Andrew Calzavara; Teresa To; Matthew B Stanbrook; Ross Upshur; Thérèse A Stukel
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

9.  A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory.

Authors:  Christine A Glady; Shawn D Aaron; Mary Lunau; Jennifer Clinch; Robert E Dales
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

10.  Pulmonary function in primary pulmonary hypertension.

Authors:  Xing-Guo Sun; James E Hansen; Ronald J Oudiz; Karlman Wasserman
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

View more
  1 in total

1.  Functional, transcriptional, and microbial shifts associated with healthy pulmonary aging in rhesus macaques.

Authors:  Nicholas S Rhoades; Michael Davies; Sloan A Lewis; Isaac R Cinco; Steven G Kohama; Luiz E Bermudez; Kevin L Winthrop; Cristina Fuss; Julie A Mattison; Eliot R Spindel; Ilhem Messaoudi
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.